Deepa H. Chand, MD, MHSA
Professor of Clinical Pediatrics (Nephrology)
Department of Pediatrics
Pediatrics Residency
Pronouns: she/her/hers
Related Sites:
About
Dr. Deepa Chand is a Board-Certified Pediatric Nephrologist with over 20 years of clinical, research, and teaching experience. She obtained her undergraduate Bachelor of Arts and Doctor of Medicine degrees from the University of Missouri at Kansas City. She also holds a Masters in Health Services Administration from Xavier University. After completing a residency in General Pediatrics at The Cleveland Clinic Foundation, she completed a fellowship in Pediatric Nephrology at Cincinnati Children’s Hospital Medical Center. She has held prestigious faculty positions at The Cleveland Clinic Foundation, Akron Children’s Hospital, and Rush University Medical Center, Washington University School of Medicine and St. Louis Children’s Hospital, and currently maintains a clinical practice at the University of Illinois College of Medicine Peoria and OSF Children’s Hospital of Illinois, where she is proud to take care of children with acute and chronic kidney care needs. She has authored over 90 publications including co-editing “The Clinician’s Manual of Pediatric Nephrology.” She has received numerous teaching awards and community leadership recognition. Her passion remains the care of children with chronic kidney disease, especially end-stage kidney disease, with an emphasis on pediatric vascular access. She has co-chaired the Pediatric Fistula First Initiative and continues to be champion of optimizing dialysis access in addition to the general care of children with kidney diseases.
Selected Publications
Chand DH, Valentini RP. International Pediatric Fistula First Initiative: A Call to Action. Am J Kidney Dis, 2008 June; 51(6): 1016-1024.
Omoloja A, Chand D, Greenbaum L, Wilson A, Bastian V, Ferris M, Bernert J, Stolfi A, Patel H. Cigarette smoking and second hand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest Pediatric Nephrology Consortium. Nephrol Dial Transplant. 2010 Aug 4.
Hooper DK, Williams JC, Carle AC, Amaral S, Chand DH, Ferris ME, Patel HP, Licht C, Barletta GM, Zitterman V, Mitsnefes M, Patel UD. The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2013 Jun;28(6):939-49. Epub 2013 Feb 17.
Chand DH, Geary D, Patel H, Greenbaum LA, Nailescu C, Brier ME and Valentini. Barriers, Biases, and Beliefs About Arteriovenous Fistula Placement in Children: A Survey of The International Pediatric Fistula First Initiative (IPFFI) Within the Midwest Pediatric Nephrology Consortium (MWPNC). Hemodial Int. 2015 Jan;19(1):100-7. doi: 10.1111/hdi.12182. Epub 2014 May 28.
Chand DH, Swartz S, Tuchman S, Valentini RP, Somers MJG. Dialysis in Children: The Pediatric Nephrology Perspective. Am J Kidney Dis. 2017 Feb;69(2):278-286. doi: 10.1053/j.ajkd.2016.09.023. Epub 2016 Dec 7.
Chand D, Mohr F, McMillan H, Fonyuy Tukov F, Montgomery K, Kleyn A, Sun R, Tauscher-Wisniewski S, Kaufmann P, Kullak-Ublick G. Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy.J Hepatol.2020;doi:https://doi.org/10.1016/j.jhep.2020.11.001.
Chand DH, Zaidman C, Arya K, Millner R, Farrar MA, Mackie FE, Goedeker NL, Dharnidharka VR, Dandamudi R, Reyna SP. Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series. J Pediatr. 2020;doi:https://doi.org/10.1016/j.jpeds.2020.11.054 [e-pub ahead of print
Hudry E, Aihara F, Meseck E, Mansfield K, McElroy C, Chand D, Tukov FF, Penraat K. Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery. Mol Ther. 2023 Oct 4;31(10):2999-3014. doi:10.1016/j.ymthe.2023.07.020. Epub 2023 Jul 28. PMID: 37515322; PMCID: PMC10556189.
Dandamudi R, Twombley K, Flynn JT, Kakajiwala A, Chand DH. Physician knowledge, attitudes, and practices regarding physical activity restrictions in pediatric hemodialysis patients. Hemodial Int. 2023 Oct;27(4):345-351. doi:10.1111/hdi.13095. Epub 2023 May 21. PMID: 37211958.
Antognini N, Portman R, Dong V, Webb NJ, Chand DH. Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach. Ther Innov Regul Sci. 2024 Mar;58(2):286-302. doi:10.1007/s43441-023-00599-x. Epub 2023 Dec 18. PMID: 38110788; PMCID: PMC10850218.
Publication Aggregators
Notable Honors
2021, Novartis Pediatric Center of Excellence First Annual Pediatric Innovators Award, Novartis
2018, Chairman's Award, AbbVie
2011, 30 for the Future Award, Greater Akron Chamber of Commerce
2008-2010, Golden Apple Excellence in Teaching, Akron Children's Hospital
Education
Medical School: University of Missouri-Kansas City (Kansas City, MO)
Masters in Health Services Administration: Xavier University (Cincinnati, OH)
Residency: The Cleveland Clinic Foundation (Cleveland, OH)
Fellowship in Pediatric Nephrology: Cincinnati Children’s Hospital Medical Center (Cincinnati, OH)
Licensures and Certifications
American Board of Pediatrics, 1999-present
American Board of Pediatrics, Subspecialty Nephrology, 2008-present
Illinois State Medical License (2012-present)
Professional Memberships
American Society of Pediatric Nephrology
American Society of Nephrology
QSource (ESRD Renal Network 10)
The IQ-Drug Induced Liver Injury Initiative
Selected Presentations
Chiuve S, Peloso P, Chand DH, Patwardhan M, Snabes M, Kilpatrick R. Risk Factors for Low Bone Mineral Density in Premenopausal Women with Endometriosis in the National Health and Nutrition Examination Survey (NHANES). Presented at the American Society for Reproductive Medicine 2018 Scientific Congress & Expo, October 6 – 10, 2018.
Invited Speaker “To Pee or Not To Pee-A Renal Overview” Pediatric Grand Rounds, University of Illinois College of Medicine November 16, 2023.
Invited Speaker “Considerations and Assessments of Renal Function in Clinical Trials” FDA-University of Maryland CERSI ADEPT 8: Workshop on drug dosing in Pediatric Patients with Renal Impairment. November 30. 2023.
Invited Speaker “Continuous Renal Replacement Therapy” Society for Critical Care Medicine-Midwest Chapter. March 20, 2024.
Breitenstein S, Chand D, Dizayee S, McKenzie J, Siapkara An, Sinsakul M, Coresh J, Ng D, Schaefer F, Warady B. Identification of disease similarity in pediatric and adult CKD: a strategy to enhance drug development in children. 56th Annual European Society of Pediatric Nephrology meeting. September 27 2024.
Invited Speaker, “Essentials of Hypertension”. Pediatric Symposium. University of Illinois College of Medicine October 24, 2204.
Regev A, Marcinak J, Zhou L, Huang F, Mehta R, Treem W, Brott D, Kordy K, Maller E, Wang LX, Chand D, Matis-Mitchell S, Porcalla A, Shneider B, Molleston EP, Lewis JH. Variability in Reference Ranges of Hepatic Biochemical Tests in Pediatric Populations: Implications for Monitoring and Assessment of Drug Induced Liver Injury. AASLD Liver Meeting. November 16, 2024.